Drugs / MGV354
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02743780 | Mar → Sep 2016 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MGV354 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02743780 ↗ |
| Action | Activate | “MGV354, a soluble guanylate cyclase (sGC) activator” PMID 29802818 ↗ May 2018 |
| Route | Topical | “topically administered MGV354” PMID 29802818 ↗ May 2018 |